|
+55
|
Are any ER juniors actually happy?
|
2w |
|
+49
|
Q&A - Equity Research
|
1mo |
|
+40
|
Lowest Comp You'd Take For Lead Coverage
|
6mo |
|
+39
|
Why do you want to be a sector-lead analyst?
|
1mo |
|
+37
|
MD hates me, what do I do?
|
4mo |
|
+35
|
Does anyone else find it very difficult to take vacations in ER?
|
3mo |
|
+32
|
Q&A New Mentor | Senior Buyside Analyst – Equity Research, Healthcare Coverage & Breaking into the Buyside
|
5mo |
|
+30
|
Struggling on my internship
|
1mo |
|
+30
|
2025 ER Comp Thread
|
6mo |
|
|
|
+28
|
Trading prestige for sanity…worth it?
|
9mo |
|
+27
|
Integrating Claude into your process
|
1mo |
|
+26
|
Finding a Way to Take the Series 86/87 Over the Summer
|
6mo |
|
+26
|
Salary Expectations on Buyside/Sellside ER
|
8mo |
|
+26
|
Equity Research to Corporate
|
8mo |
|
+25
|
ER outlook
|
2mo |
|
+25
|
Non-conventional exits from ER
|
9mo |
|
+25
|
Including Stock Thesis in Email
|
9mo |
|
+23
|
Incoming ER Associate - any tips/info/words of wisdom?
|
8mo |
|
+22
|
Full-Time Equity Research Recruiting
|
2mo |
|
+22
|
Started ER Internship, Reconsidering: Exit Opps?
|
1mo |
|
+22
|
RE > ER
|
11mo |
|
+21
|
Sharing my Stock Pitch Report Project with y’all.
|
1w |
|
+21
|
Stock Pitch Support
|
7mo |
|
+20
|
Article: UBS: The Fragile Facade of a Post-Merger Powerhouse
|
4mo |
|
|
|
+19
|
Trying to Break into ER
|
10mo |
|
+18
|
Is Equity Research Still a Good Career Path in 2026?
|
2w |
|
+18
|
Former Pharma scientist with sell-side biotech ER experience — interview processes keep stalling, what am I missing
|
3mo |
|
+18
|
ER Pulse Check... How We Doing?
|
4mo |
|
+18
|
Is Biotech/Healthcare ER worth taking?
|
2w |
|
+18
|
Aside from an easier earnings season, why leave sell side for a LO?
|
5mo |
|
+18
|
Sector coverage - specialist vs generalist
|
10mo |
|
+17
|
Equity Research Today: What skills are actually most valuable for entry-level analysts?
|
4mo |
|
+16
|
Intel (INTC): My Bull Case Still Doesn't Justify the Current Stock Price
|
3mo |
|
+16
|
Looking for help in choosing London Master’s degree
|
5mo |
|
+16
|
How to approach interview with director of research
|
7mo |
|
+15
|
Is AI finally starting to kill Equity Research?
|
1d |
|
+15
|
How do you actually build your football fields — CapIQ, template, or from scratch?
|
1mo |
|
+15
|
Built a desktop valuation app (DCF / DDM / reverse DCF) so I'd stop rebuilding Excel models for every pitch — would value some ER feedback
|
2mo |
|
+15
|
ER Case Study guidance
|
4mo |
|
+15
|
ER 27 Timeline
|
4mo |
|
+15
|
What should I be reading?
|
5mo |
|
+15
|
What to do?
|
7mo |
|
+15
|
Evercore Modeling Assessment
|
10mo |
|
+14
|
How Concise to Keep Networking Emails
|
1w |
|
+14
|
Deleted
|
1mo |
|
+14
|
Pivot from Top European Engineering to Equity Research: Strategy Review
|
1mo |
|
+14
|
How do you actually trace second-order effects after a market event?
|
1mo |
|
+14
|
Rising junior at semi-target, fumbled sophomore recruiting — how cooked am I really?
|
3mo |
|
+13
|
Am I living in la la Land
|
1w |
|
+13
|
From BIG4 Audit to Equity/Credit Research -> how to break in
|
2w |
|
+13
|
ER--Unusually long reference checks post-superday
|
2mo |
|
+13
|
Why does any firm issue a hold rating?
|
6mo |
|
+13
|
Technicals to Focus on for ER?
|
9mo |
|
+13
|
Ai is Infecting All of ER
|
9mo |
|
+12
|
Bored on the buyside
|
4mo |
|
+12
|
Texas ER work life?
|
4mo |
|
+12
|
Outsourced IR firms
|
9mo |
|
+11
|
Thoughts on boutique ER firm opportunity and options afterwards
|
3mo |
|
+11
|
PayPal (PYPL): Why Is the Market Valuing PayPal Like a Low-Growth Company Despite Strong Free Cash Flow?
|
3mo |
|
+11
|
How easy is it to switch sectors once you start your career
|
6mo |
|
+11
|
ER interview with lead analyst
|
6mo |
|
+11
|
IM to ER FT Recruiting
|
7mo |
|
+11
|
High-Efficiency Outsourcing New Infrastructure
|
7mo |
|
+10
|
How to handle call with DOR
|
1d |
|
+10
|
Which masters after Equity Research
|
2mo |
|
+10
|
Automating Equity Research Workflows — From 2–3 Hours to ~20 Minutes
|
4mo |
|
+10
|
What type of training is given to ER associates out of school versus lateral hires (untraditional backgrounds)
|
6mo |
|
+10
|
MS ER SA 2027 proccess?
|
6mo |
|
+10
|
Why should I choose to stay on the sellside?
|
7mo |
|
+10
|
Equity Sales - Exits?
|
8mo |
|
+10
|
Reach out to Analyst?
|
9mo |
|
+10
|
UBS ER 2026
|
6mo |
|
+9
|
Best ER Adjacent Careers
|
2w |
|
+9
|
Failing at recruiting - where from here?
|
3w |
|
+9
|
The Most Detailed Technical Breakdown of $MAAS: Five Months Later, Is the Party Over?
|
3w |
|
+9
|
what to buy at this point
|
3w |
|
+9
|
AI data centers are slamming head-on into the physical limits of the grid?
|
3w |
|
+9
|
How Are People Actually Thinking About NVDA Into Earnings?
|
3w |
|
+9
|
Technical/Data Background → Semiconductor Equity Research: Built an AVGO Earnings Model and Would Appreciate ER Feedback
|
4w |
|
+9
|
Anyone recently interviewed for Bloomberg Intelligence Equity Research?
|
1mo |
|
+9
|
VP shortlist at current shop vs. signed BB offer — thoughts?
|
1mo |
|
+9
|
Who would you hire out of these two?
|
2d |
|
+9
|
What are the best paths into equity research through a life sciences undergrad?
|
1mo |
|
+9
|
Rising Sophomore clueless about recruiting timeline
|
3mo |
|
+9
|
Is equity research dead? If not, what aspects are still viable?
|
3mo |
|
+9
|
CC student, help choose schools
|
4mo |
|
+9
|
Notes from JBL's Q2 Earnings Call: Margins, Capex, and the FY27 Bridge
|
4mo |
|
+9
|
IB SA -> ER
|
5mo |
|
+9
|
Ford's CEO and CFO sounded exactly the same on the Q4 call. That's weird, right?
|
5mo |
|
+9
|
Let go from LO cross-asset seat. How to position next move?
|
5mo |
|
+9
|
Bloomberg Intelligence vs Sell-Side Equity Research → Buyside Path?
|
5mo |
|
+9
|
Analyzing Distribution Patterns: Form 4 Outflows and Foundry Cycles
|
5mo |
|
+9
|
are in-person channel checks for consumer companies useful
|
5mo |
|
+9
|
What is the best path for me as MBA student to HF
|
3mo |
|
+9
|
Institutional Capital Allocation: Decoding the Macro Shift Through Regulatory Disclosures
|
5mo |
|
+9
|
Evaluating the Disconnect: Institutional Sentiment vs. C-Suite Capital Allocation in Discount Retail
|
5mo |
|
+9
|
Hi! Interview for Research Associate position
|
6mo |
|
+9
|
Appropriate discount rate for a taxable and nontaxable entity investing in the same project
|
6mo |
|
+9
|
New Grad ER Associate -email from future boss about86/87.
|
6mo |
|
+9
|
Replying to recruiter a week late…
|
7mo |
or Want to Sign up with your social account?